Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

類似資料

• Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
  著者:: Polley, Mei-Yin C., 等
  出版事項: (2010)
• The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
  著者:: Han, Seunggu J., 等
  出版事項: (2015)
• Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials()
  著者:: Wen, Qiuting, 等
  出版事項: (2015)
• Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma
  著者:: Essock-Burns, Emma, 等
  出版事項: (2011)
• Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
  著者:: Butowski, Nicholas, 等
  出版事項: (2011)